DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
4 articles
AstraZeneca's in vivo CAR-T therapy has shown early responses in 50% of patients, according to Endpoints News.
Triangle Healthâs $4 million round arrives as the FDA tightens rules on AI-driven medical advice tools.
Rocheâs breast cancer pill persevERA flunks crucial Phase 3 trial, costing the pharma giant its blockbuster hopes worth billions.
Sanofiâs two lucrative deals with Earendil Labs signal Big Pharmaâs growing appetite for AI-designed drugsâbefore a single one hits the market.